Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells

Jones, Courtney L., Stevens, Brett M., D'Alessandro, Angelo, Reisz, Julie A., Culp-Hill, Rachel, Nemkov, Travis, Pei, Shanshan, Khan, Nabilah +8 more·2018·Cancer Cell

DOI 10.1016/j.ccell.2018.10.005

Cited by (591)

Items 301–400 of 591

Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response
Sarah J. Skuli, A’ishah Bakayoko, Marisa Kruidenier, Bryan Manning, Paige Pammer, Akmal Salimov, Owen Riley, Gisela Brake-Sillá, Derrick L. Dopkin, Michael Bowman et al. · 2025 · Leukemia
Whole transcriptome sequencing and integrated network analysis elucidates the effects of 3,8-Di-O-methylellagic acid 2-O-glucoside derived from Sanguisorba offcinalis L., a novel differentiation inducer on erythroleukemia cells
Long Wang, Sha Liu, Xiaoxuan Li, Xin Shen, Jing Zeng, Jiesi Luo, Ke-Ru Li, Anguo Wu, Lu Yu, Dalian Qin et al. · 2021 · Pharmacological Research
DNMT3A R882H mutation promotes acute leukemic cell survival by regulating glycolysis through the NRF2/NQO1 axis
Xuan Chu, Liang Zhong, Wenran Dan, Xiao Wang, Zhonghui Zhang, Zhenyan Liu, Yang Lu, Xin Shao, Ziwei Zhou, Shuyu Chen et al. · 2023 · Cellular Signalling
Molecular mechanisms for stemness maintenance of acute myeloid leukemia stem cells
Jiazhen Wang, Peipei Wang, Tiantian Zhang, Zhuying Gao, Jing Wang, Mengdie Feng, Rong L. Yin, Haojian Zhang · 2019 · Blood Science
Venetoclax in AML: Where We Are and Where We Are Headed
Daniel Aaron Pollyea · 2020 · Clinical Lymphoma Myeloma & Leukemia
Enriching for human acute myeloid leukemia stem cells using reactive oxygen species-based cell sorting
Brett M. Stevens, Cristiana O’Brien, Craig T. Jordan, Courtney L. Jones · 2020 · STAR Protocols
Cell Biology Meets Cell Metabolism: Energy Production Is Similar in Stem Cells and in Cancer Stem Cells in Brain and Bone Marrow
Cornelis J.F. Van Noorden, Barbara Breznik, Metka Novak, Amber J. van Dijck, Saloua Tanan, Miloš Vittori, Urban Bogataj, Noëlle Bakker, Joseph David Khoury, Remco Jurriaan Molenaar et al. · 2021 · Journal of Histochemistry & Cytochemistry
SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cells
Moran Wang, Ruiqi Zhu, Donald Small, Lan Lin, Li Li, Shengling Ma, Linghui Xia, Shanshan Luo, Wenjuan He, Jianming Yu et al. · 2025 · Leukemia
Amino Acid Metabolic Vulnerabilities in Acute and Chronic Myeloid Leukemias
Aboli Bhingarkar, Hima V. Vangapandu, Sanjay Rathod, Keito Hoshitsuki, Christian Antonio Fernandez · 2021 · Frontiers in Oncology
Regulation of leukemogenesis via redox metabolism
Zhuo Zhang, Chiqi Chen, Li Xie, Junke Zheng, Yuzheng Zhao · 2023 · Trends in Cell Biology
Untargeted metabolomic and lipidomic analyses reveal lipid dysregulation in the plasma of acute leukemia patients
Cindy Arévalo, Laura Rojas, Mary Santamaria, Luisana Molina Pimienta, Lina Arbeláez, Paula Sánchez, Ricardo Ballesteros-Ramírez, Mónica Arévalo-Zambrano, Sandra Quijano, Mónica P. Cala et al. · 2023 · Frontiers in Molecular Biosciences
Metabolic dependencies of acute myeloid leukemia stem cells
Xiangguo E. Shi, Mengdie Feng, Daisuke Nakada · 2024 · International Journal of Hematology
Targeting Ca2+ and Mitochondrial Homeostasis by Antipsychotic Thioridazine in Leukemia Cells
Vivian Moraes, Vivian M. Santos, Eloah Rabello Suarez, Letícia Silva Ferraz, Rayssa de Mello Lopes, Giuliana P. Mognol, Joana D'Arc Campeiro, João Agostinho Machado‐Neto, Fábio Dupart Nascimento, Mirian A.F. Hayashi et al. · 2022 · Life
SCD1 Sustains Homeostasis of Bulge Niche via Maintaining Hemidesmosomes in Basal Keratinocytes
Yueqing Xue, Liangyu Lin, Qing Li, Keli Liu, Mingyuan Hu, Jiayin Ye, Jianchang Cao, Jingjie Zhai, Fanjun Zheng, Yu Wang et al. · 2022 · Advanced Science
High developmental pluripotency‑associated 4 expression promotes cell proliferation and glycolysis, and predicts poor prognosis in non‑small‑cell lung cancer
Longfei Li, Yufeng Wang, Qiang Wang, Jingming Qu, Xiangju Wei, Jilei Xu, Yuanjin Wang, Feng Suo, Yanjie Zhang · 2019 · Molecular Medicine Reports
Dissecting the Role of Autophagy-Related Proteins in Cancer Metabolism and Plasticity
Liliana Torres-López, Oxana R. Dobrovinskaya · 2023 · Cells
Emerging and Future Targeted Therapies for Pediatric Acute Myeloid Leukemia: Targeting the Leukemia Stem Cells
Lindsey A. Murphy, Amanda C. Winters · 2023 · Biomedicines
Multi-omics analysis-based clinical and functional significance of a novel prognostic and immunotherapeutic gene signature derived from amino acid metabolism pathways in lung adenocarcinoma
Huihui Xiang, Rika Kasajima, Koichi Azuma, Tomoyuki Tagami, Asami Hagiwara, Yoshiro Nakahara, Haruhiro Saito, Yuka Igarashi, Feifei Wei, Tatsuma Ban et al. · 2024 · Frontiers in Immunology
Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia
Elissa Tjahjono, Megan R. Daneman, Bernadetta Meika, Alexey V. Revtovich, Natalia V. Kirienko · 2025 · Frontiers in Oncology
Leukemia Stem Cells in the Pathogenesis, Progression, and Treatment of Acute Myeloid Leukemia
Kanak Joshi, Lei Zhang, Peter Breslin, Jiwang Zhang · 2019 · Advances in experimental medicine and biology
The Interactome between Metabolism and Gene Mutations in Myeloid Malignancies
Carmelo Gurnari, Simona Pagliuca, Valeria Visconte · 2021 · International Journal of Molecular Sciences
A statistical network pre-processing method to improve relevance and significance of gene lists in microarray gene expression studies
Giuseppe Agapito, Marianna Milano, Mario Cannataro · 2022 · BMC Bioinformatics
Amino acids in hematologic malignancies: Current status and future perspective
Mengyao Wang, Ailin Zhao, Meng Li, Ting Niu · 2023 · Frontiers in Nutrition
Cuproptosis-related lncRNAs forecast the prognosis of acute myeloid leukemia
Tong Zhang, Danying Liao, Yu Hu · 2023 · Translational Cancer Research
SCP4-STK35/PDIK1L complex is a dual phospho-catalytic signaling dependency in acute myeloid leukemia
Sofya A. Polyanskaya, Rosamaria Y. Moreno, Bin Lu, Ruopeng Feng, Yu Yao, Seema Irani, Olaf Klingbeil, Zhaolin Yang, Yiliang Wei, Osama E. Demerdash et al. · 2022 · Cell Reports
Therapeutic Applications of Azanucleoside Analogs as DNA Demethylating Agents
Fallon Gallimore, Tamer E. Fandy · 2023 · Epigenomes
Cancer stem cells: advances in the glucose, lipid and amino acid metabolism
Weina Kong, Yunge Gao, Shuhua Zhao, Hong Yang · 2023 · Molecular and Cellular Biochemistry
Aberrant Lipid Metabolic Signatures in Acute Myeloid Leukemia
Pooja Singh, Roopak Murali, Sri Gayathri Shanmugam, Steve Thomas, Julius Xavier Scott, Sudha R. Warrier, Frank Arfuso, Arun Dharmarajan, Rajesh Kumar Gandhirajan · 2024 · Stem Cells
FAM83B regulates mitochondrial metabolism and anti-apoptotic activity in pulmonary adenocarcinoma
Jiajia Wang, Panpan Li, Limin Sun, Jing Zhang, Ke Yue, Yan Wang, Xiaojuan Wu · 2024 · APOPTOSIS
From Chemotherapy to Targeted Therapy: Unraveling Resistance in Acute Myeloid Leukemia Through Genetic and Non-Genetic Insights
Shuting Cao, Qiuxia Wang, Ganqian Zhu · 2025 · International Journal of Molecular Sciences
S-glutathionylation in cancer: from fundamental mechanisms to clinical applications
Shuai Dong, Li Linghu, Desheng Xiao, Shuang Liu, Yongguang Tao · 2025 · Pharmacological Research
Small-molecule OPA1 inhibitors reverse mitochondrial adaptations to overcome therapy resistance in acute myeloid leukemia
Sofia La Vecchia, Saurav Doshi, Petros Antonoglou, Tanima Kundu, Wafa Al-Santli, Kleopatra Avrampou, Matthew T. Witkowski, Anna Pellattiero, Federico Magrin, Kristina T. Ames et al. · 2025 · Science Advances
Why are hypomethylating agents or low-dose cytarabine and venetoclax so effective?
Daniel Aaron Pollyea, Craig T. Jordan · 2019 · Current Opinion in Hematology
Advances in Understanding the Links between Metabolism and Autophagy in Acute Myeloid Leukemia: From Biology to Therapeutic Targeting
Ernestina Saulle, Isabella Spinello, Maria Teresa Quaranta, Catherine Labbaye · 2023 · Cells
The Evolving AML Genomic Landscape: Therapeutic Implications
Sachi Horibata, George Alyateem, Christin B. DeStefano, Michael M. Gottesman · 2020 · Current Cancer Drug Targets
The evolution of leukaemia from pre‐leukaemic and leukaemic stem cells
Liran I. Shlush, Tzah Feldman · 2021 · Journal of Internal Medicine
Transcriptional and phenotypic heterogeneity underpinning venetoclax resistance in AML
Vakul Mohanty, Natalia Baran, Yuefan Huang, Cassandra L. Ramage, Laurie Cooper, Shan He, Ramiz Iqbal, May Daher, Jeffrey W Tyner, Gordon Brent Mills et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress
Jenna L. Carter, Yongwei Su, Eman T. Al‐Antary, Jianlei Zhao, Xinan Qiao, Guan Wang, Holly J. Edwards, Lisa Polin, Juiwanna Kushner, Sijana H. Dzinic et al. · 2025 · Journal of Experimental & Clinical Cancer Research
The STAT3-VDAC1 axis modulates mitochondrial function and plays a critical role in the survival of acute myeloid leukemia cells
Kellen B. Gil, Jamie L. Borg, Rosana Moreira Pereira, Anagha Inguva Sheth, Geovana Araujo, Jeremy Rahkola, William Showers, Abby Grier, Angelo D’Alessandro, Clayton A. Smith et al. · 2025 · Haematologica
Metabolic reprogramming represents a targetable mechanism to overcome acquired resistance to venetoclax in acute myeloid leukemia
Gustavo Nery de Queiroz, Keli Lima, Marcella Cipelli, Victoria Tomaz, Luiz Gustavo Ferreira Cortez, Marina de Franca Basto Silva, Rafael Lucas Muniz Guedes, Paulo Vidal Campregher, Eduardo Magalhães Rego, Niels Olsen Saraiva Câmara et al. · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Dysregulated Metabolism in Cancer
Asmida Isa · 2022 · Biomedical Research and Therapy
Venetolax with Azacitidine Drains Fuel from AML Stem Cells
Daisuke Nakada · 2019 · Cell stem cell
Cancer Stem Cells and Stem Cell Tumors in Drosophila
Shree Ram Singh, Poonam Aggarwal, Xianyu Steven Hou · 2019 · Advances in experimental medicine and biology
Glycine/glycine N-methyltransferase/sarcosine axis mediates benzene-induced hematotoxicity
Wei Zhang, Xiaoli Guo, Jing Ren, Yujiao Chen, Jingyu Wang, Ai Gao · 2021 · Toxicology and Applied Pharmacology
GPAM mediated lysophosphatidic acid synthesis regulates mitochondrial dynamics in acute myeloid leukemia
Hidetoshi Irifune, Yu Kochi, Toshihiro Miyamoto, Teppei Sakoda, Koji Kato, Yuya Kunisaki, Koichi Akashi, Yoshikane Kikushige · 2023 · Cancer Science
Phospholipid metabolism regulates AML growth and stemness
Mingjing Xu, Ayesh K. Seneviratne, Aaron David Schimmer · 2019 · Aging
The Intriguing Clinical Success of BCL-2 Inhibition in Acute Myeloid Leukemia
Daniel Aaron Pollyea, Shanshan Pei, Brett M. Stevens, Clayton A. Smith, Craig T. Jordan · 2020 · Annual Review of Cancer Biology
Hematopoietic Stem Cells and Their Bone Marrow Niches
Sandra Pinho, Meng Liang Zhao · 2023 · Advances in experimental medicine and biology
Nicotinamide benefited amino acid metabolism and rumen fermentation pattern to improve growth performance of growing lambs
YuAng Wang, Hao Wu, Yiwei Zhang, Mingfeng Fei, Zhefeng Li, Daxi Ren, Chong Wang, Xiaoshi Wei · 2024 · Animal Bioscience
BCL-2 inhibition in acute myeloid leukemia: resistance and combinations
Qi Zhang, Zhe Wang, Marina Konopleva · 2024 · Expert Review of Hematology
Guanine nucleotide biosynthesis blockade impairs MLL complex formation and sensitizes leukemias to menin inhibition
Xiangguo E. Shi, Minhua Li, Zian Liu, Jonathan Tiessen, Yuan Li, Jing Zhou, Yudan Zhu, Swetha Mahesula, Ding Qing, Lin Tan et al. · 2025 · Nature Communications
Cancer stem cells amino acid metabolism: Roles, mechanisms, and intervention strategies
Yi Gong, Xirui Wang, Wenlong Chen, Hsiang‐i Tsai, Yanfang Liu · 2025 · Cellular Signalling
Deciphering and targeting oncogenic pathways through integrated approaches and amino acid metabolism in hematologic malignancies
Farhan Ikhtiar, Adil Jamal, Syed M. Safeer Mehdi Bokhari · 2025 · Discover Oncology
Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias
Xingjian Zhai, Xiaoyan Jiang · 2022 · Biomedicines
Hexamethylene amiloride synergizes with venetoclax to induce lysosome-dependent cell death in acute myeloid leukemia
Xinya Jiang, Kexiu Huang, Xiaofan Sun, Yue Li, Lei Hua, Fangshu Liu, Rui Huang, Juan Du, Hui Zeng · 2023 · iScience
Mechanisms of resistance to venetoclax in hematologic malignancies
Klaudia Zielonka, Krzysztof Jamroziak · 2024 · Advances in Clinical and Experimental Medicine
8-Cl-Ado and 8-NH2-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute myeloid leukemia
Jiamin Guo, Ralf Buettner, Li Du, Zhenlong Li, Wei Liu, Rui Jun Su, Zhenhua Chen, Yuan Che, Yi qin Zhang, Rui Ma et al. · 2024 · Leukemia
Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center
Ziyi Hao, Ying-Ying Fei, Juan Chen, Sailan Huang, Li Wang, Youhuan Yu, Meiru Bian, Yejun Si, Xingxia Zhang, Xiaotian Yang et al. · 2024 · Hematology
Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go?
Jennifer Marvin‐Peek, Jason S. Gilbert, Daniel Aaron Pollyea, Courtney Denton Dinardo · 2024 · American Journal of Hematology
The role of dysregulated metabolism and associated genes in gastric cancer initiation and development
Zhengyan Jiang, Zhengrong Gu, Xianyan Lu, Wei Wen · 2024 · Translational Cancer Research
The Role of Metabolism in the Development of Personalized Therapies in Acute Myeloid Leukemia
Vilma Dembitz, Paolo Gallipoli · 2021 · Frontiers in Oncology
Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia
Amandeep Salhotra, Ni‐Chun Tsai, Jianying Zhang, Dat Ngo, Ahmed M. Aribi, Karamjeet Sandhu, Brian J. Ball, Monzr M. Al Malki, Haris Ali, Paul Koller et al. · 2021 · British Journal of Haematology
Synergy of Venetoclax and 8-Chloro-Adenosine in AML: The Interplay of rRNA Inhibition and Fatty Acid Metabolism
Dinh Hoa Hoang, Corey James Morales, Ivan Rodriguez Rodriguez, Melissa Valerio, Jiamin Guo, Min-Hsuan Chen, Xiwei Wu, David A. Horne, Varsha V. Gandhi, Lisa S. Chen et al. · 2022 · Cancers
Identification of an amino acid metabolism-associated gene signature predicting the prognosis and immune therapy response of clear cell renal cell carcinoma
Fan Zhang, Junyu Lin, Daiwen Zhu, Yongquan Tang, Yiping Lu, Zhihong Liu, Xianding Wang · 2022 · Frontiers in Oncology
Lipid profile as a novel prognostic predictor for patients with acute myeloid leukemia
Shenrui Bai, Huizhong Wang, Ruonan Shao, Bibo Fu, Shujing Lu, Jingzi Wang, Yue Lü, Hua Wang · 2023 · Frontiers in Oncology
Identification of a metabolic gene panel to predict the prognosis of myelodysplastic syndrome
Fang Hu, Siliang Chen, Yu‐jun Dai, Yun Wang, Zhe-Yuan Qin, Huan Li, Lingling Shu, Jinyuan Li, Han‐ying Huang, Yang Liang · 2020 · Journal of Cellular and Molecular Medicine
Metabolic Reprogramming and Cell Adhesion in Acute Leukemia Adaptation to the CNS Niche
Nitesh Devinarayan Sharma, Esraa F. Keewan, Ksenia Matlawska‐Wasowska · 2021 · Frontiers in Cell and Developmental Biology
Oncogenic Mechanisms and Therapeutic Targeting of Metabolism in Leukemia and Lymphoma
Maximilian F. Stahl, Zachary Drew Epstein-Peterson, Andrew M. Intlekofer · 2020 · Cold Spring Harbor Perspectives in Medicine
A guide to epigenetics in leukaemia stem cells
Shuchi Agrawal Singh, Jaana Bagri, Nathalie Sakakini, Brian J.P. Huntly · 2023 · Molecular Oncology
Histidine re-sensitizes pediatric acute lymphoblastic leukemia to 6-mercaptopurine through tetrahydrofolate consumption and SIRT5-mediated desuccinylation
Na Dong, Huixian Ma, Xueqin Liu, Li Dong, Linghong Liu, Qing Shi, Xiuli Ju · 2024 · Cell Death and Disease
Chiglitazar diminishes the warburg effect through PPARγ/mTOR/PKM2 and increases the sensitivity of imatinib in chronic myeloid leukemia
Hongpeng Duan, Qian Lai, Yuelong Jiang, Liuzhen Yang, Manman Deng, Zhijuan Lin, Weihang Shan, Mengya Zhong, Jingwei Yao, Li Zhang et al. · 2024 · Experimental Hematology and Oncology
Pharmacological inhibition of miR-126 enhances venetoclax activity in acute myeloid leukemia
Leying Zhang, HyunJun Kang, Melissa Valerio, Dinh Hoa Hoang, Khyatiben V. Pathak, Krystine Garcia‐Mansfield, Xiyuan Lu, Wancheng Guo, Yu-Hsuan Fu, Xin He et al. · 2025 · Blood
Novel Mango Ginger Bioactive (2,4,6-Trihydroxy-3,5-diprenyldihydrochalcone) Inhibits Mitochondrial Metabolism in Combination with Avocatin B
Varsha Jayasankar, Nikolina Vrdoljak, Alessia Roma, Nawaz Ahmed, Matthew Tcheng, Mark David Minden, Paul A. Spagnuolo · 2022 · ACS Omega
Challenges facing minimal residual disease testing for acute myeloid leukemia and promising strategies to overcome them
Siqi Li, Man Chen, Xi-Yi Huang, Hui Wang, Ying‐Jun Chang · 2023 · Expert Review of Hematology
Targeting Fatty Acid Metabolism Abrogates the Differentiation Blockade in Preleukemic Cells
Xiaoyu Liu, Yu Liu, Qing Rao, Yihan Mei, Haiyan Xing, Runxia Gu, Junli Mou, Manling Chen, Fan Ding, Wanqing Xie et al. · 2024 · Cancer Research
One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies
Antonia Kalushkova, Patrick Nylund, Alba Atienza Párraga, Andreas Lennartsson, Helena Jernberg‐Wiklund · 2021 · Epigenomes
Keeping up with venetoclax for leukemic malignancies: key findings, optimal regimens, and clinical considerations
Maria Tariq Siddiqui, Marina Y Konopleva · 2021 · Expert Review of Clinical Pharmacology
Clinically Relevant Oxygraphic Assay to Assess Mitochondrial Energy Metabolism in Acute Myeloid Leukemia Patients
Quentin Fovez, William Laine, Laure Goursaud, Céline Berthon, Nicolas Germain, Claire Degand, Jean‐Emmanuel Sarry, Bruno Quesnel, Philippe Marchetti, Jérôme Kluza · 2021 · Cancers
Cancer drug resistance in multiple myeloma
Fatih Mehmet Uckun · 2022 · Cancer Drug Resistance
Targeting apoptosis dysregulation in myeloid malignancies - The promise of a therapeutic revolution
Enrico Santinelli, Maria Rosaria Pascale, Zhuoer Xie, Talha Badar, Maximilian F. Stahl, Jan Philipp Bewersdorf, Carmelo Gurnari, Amer Methqal Zeidan · 2023 · Blood Reviews
Venetoclax for the treatment of elderly or chemotherapy-ineligible patients with acute myeloid leukemia: a step in the right direction or a game changer?
Sonal Agarwal, Andrew Kowalski, Molly Schiffer, Jennifer C. Zhao, Jan Philipp Bewersdorf, Amer Methqal Zeidan · 2021 · Expert Review of Hematology
The mitochondria as an emerging target of self-renewal in T-cell acute lymphoblastic leukemia
Majd A. Al‐Hamaly, Evelyn Winter, Jessica S. Blackburn · 2025 · Cancer Biology & Therapy
SUCLG1 deficiency-induced histone succinylation impairs oncogene expression in acute myeloid leukemia
Mengqing Gao, Minhui Shi, Hao Ding, Lei Xu, Na Zhao, Li Wang, Shujuan Huang, Hui Jiang, Ekaterina Bourova-Flin, Jian‐Qing Mi et al. · 2025 · Cell Reports
Factors affecting response and resistance to venetoclax in acute myeloid leukemia
Michael D. Diamantidis · 2025 · Frontiers in Oncology
Targeting leukemic stem cell biomechanics suppresses stemness and enhances NK cell-mediated immunotherapy
Mingming Zhu, Haoxiang Yang, Kailong Qiu, Beibei Huang, Tingting Liang, Yan Wang, Huan Li, Mingming Wu, Xinru Liu, Na Zhao et al. · 2025 · Nature Communications
DDX6 undergoes phase separation to modulate metabolic plasticity and chemoresistance
Hongjie Bi, Wei Li, Lili Ren, H. Zhang, Lei Dong, Anthony W.H. Chan, Xueer Wang, Lu Yang, Xiaoxu Zhang, Meilin Xue et al. · 2025 · Nature Communications
Intrinsic and niche-dependent metabolic regulation of haematopoietic stem cells and implications for leukaemogenesis
Ayşegül Erdem, Claudia Morganti, Haruhito Totani, Nick van Gastel, Keisuke Ito · 2026 · Nature Cell Biology
Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML.
A. Waclawiczek, Aino-Maija Leppä, S. Renders, Ines Bergerweiss, Karolin Stumpf, Barbara Betz, Susanna Gabrowski, Frank Y. Huang, M. Lalioti, Bendix Hempel et al. · 2026 · Cell Stem Cell
Acute myeloid leukemia in elderly patients: New targets, new therapies
Hae J. Park, Mark A. Gregory · 2023 · Aging and Cancer
Mechanisms of resistance to hypomethylating agents and BCL-2 inhibitors
Sudhamsh Reddy Desai, Samarpana Chakraborty, Aditi Shastri · 2023 · Best Practice & Research Clinical Haematology
Venetoclax in combination with chidamide and azacitidine for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia with the MLL-AF4 gene: a case report and literature review
Xuelian Jin, Zhigang Liu, Yu Wu, Jie Ji · 2025 · Frontiers in Immunology
Help from outside: cysteine to survive in AML
Lucille Stuani, Jean‐Emmanuel Sarry · 2019 · Blood
B-cell lymphoma-2 inhibition and resistance in acute myeloid leukemia
Lindsay R. Wilde, Sabarina Ramanathan, Margaret T. Kasner · 2020 · World Journal of Clinical Oncology
THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA
Elvira Pelosi, Germana Castelli, Ugo Testa · 2022 · Mediterranean Journal of Hematology and Infectious Diseases
Construction and validation of a fatty acid metabolism risk signature for predicting prognosis in acute myeloid leukemia
Miao Chen, Yuan Tao, Pengjie Yue, Feng Guo, Xiaojing Yan · 2022 · BMC Genomic Data
A Leukemic Target with a Thousand Faces: The Mitochondria
Beatrice Maffeo, Cristina Panuzzo, A Moraca, Daniela Cilloni · 2023 · International Journal of Molecular Sciences
SOHO State of the Art Updates and Next Questions: Understanding and Overcoming Venetoclax Resistance in Hematologic Malignancies
Mark Forsberg, Marina Y Konopleva · 2023 · Clinical Lymphoma Myeloma & Leukemia
Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia
Jamshid Sorouri Khorashad, Siân Rizzo, Alex Tonks · 2024 · Cancer Drug Resistance
Metabolic Flexibility in Leukemia—Adapt or Die
Boaz Nachmias, Aaron David Schimmer · 2018 · Cancer Cell
Acute myeloid leukemia drug development in the post‐venetoclax era
Daniel Aaron Pollyea · 2019 · American Journal of Hematology